The Europe cell line development serum market is expected to reach US$ 422.61 million in 2027 from US$ 268.68 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. Increasing adoption of regenerative medicines, rising prevalence of cancer across the world, and increasing investments in R&D by pharmaceutical and biotechnology companies are the key factors driving the growth of the Europe cell line development serum market. However, risks associated with cell line contamination are expected to hamper the market during the forecast period. The cell line can be defined as cell culture, selected for uniformity from a cell population derived from a usually homogeneous tissue source in a growing medium under controlled conditions.The serum serves as a carrier for enzymes, micronutrients, lipids, and trace elements into the cell and regulates cell membrane permeability.
Tissue Engineering has now evolved into the broader area of regenerative medicine, which focuses on developing clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, using cell engineering.Regenerative therapies using cell lines and culture can help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries.
Thus, a surge in the use of regenerative medicines propels the cell line development serum market. The COVID-19 pandemic has negatively impacted all drug development phases and forced various pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. Moreover, the continuing COVID-19 crisis is likely to restrain the cell line manufacturers to meet the future demand for cell and gene therapies.
Based on type, the Europe cell line development serum market is segmented into fetal bovine serum, porcine serum, adult bovine serum, horse serum, and other animal serum. The fetal bovine serum segment held a significant share of the market and is estimated to register the highest CAGR during the forecast period. Based on application, the Europe cell line development serum market is segmented into tissue engineering and regenerative medicines, academic research, drug discovery, toxicity testing, and bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is anticipated to register the highest CAGR in the market during the forecast period. Some of the primary and secondary sources associated with the Europe cell line development serum market report are European Forum for Industrial Biotechnology and the Bioeconomy Alliance (EFIBA), European Collection of Cell Cultures (ECACC); Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS); and the World Health Organization (WHO); among others.
Our reports have been used by over 10K customers, including:
206 pages •
By The Business Research Company
• Dec 2020
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market. Description: Where is the largest and fastest growing...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
The market for cell culture is driven by factors such as rising demand for vaccines, artificial organs and biopharmaceuticals, and growing focus on personalized medicine. Immunization is the most valuable and cost-effective intervention that delivers better health as well as social and economic benefits. Annually, around 2 to 3 million...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The fill finish manufacturing market was valued at US$ 6,129.03 million in 2019 and is projected to reach US$ 12,547.23 million by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027. The growth of the fill finish manufacturing market is mainly attributed to factors such as rising adoption of prefilled syringes for parenteral...
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. Technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and...
The global in vitro toxicology testing market is projected to grow at a CAGR of 10.3%.
The in vitro toxicology testing market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect...
The Europe biosafety cabinets marketis expected to reachUS$ 89.30 millionby 2027 from US$ 48.92 millionin 2019. The market is estimated to grow at a CAGR of 7.8% from 2020 to 2027. The factors that are driving growth of the market are anexpansion of research and development activities due to huge investments by private players and government...
The biosafety cabinets market was valued at US$ 166.67 million in 2019 and is projected to reach US$ 312.90 million by 2027; it is expected to grow at a CAGR of 8.2%during 2020-2027. The growth of the biosafety cabinets market is mainly attributed to factors such as the increasing prevalence of infectious diseases and rising technological...
Biopharmaceutical
Infectious Disease
World
APAC
Europe
Health Expenditure
Infectious Disease Incidence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.